Episodes
Ask host to enable sharing for playback control

Scaling Success: Hypertension Control at MPCA with the AMA MAP™ Program

6/23/2025
Host: Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA Guest: Faiyaz Syed MD, MPH The Michigan Primary Care Association (MPCA) recently partnered with the AMA to implement the AMA MAP™ Hypertension Quality Improvement Program at two pilot health centers. After this collaboration resulted in a 6 percent improvement in hypertension control, it’s now expanding to all other MPCA health centers and could even focus on other conditions like diabetes. Joining Dr. Mary Katherine Cheeley to share his experience with the AMA MAP™ program is Dr. Faiyaz Syed, Chief Medical Officer for the MPCA.

Duration:00:11:27

Ask host to enable sharing for playback control

Skin Disease and Cardiovascular Risk: Uncovering a Critical Clinical Connection

6/10/2025
Host: Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA Guest: Joel M. Gelfand, MD, MSCE, FAAD Guest: Michael S. Garshick, MD Inflammatory skin diseases like psoriasis don’t just affect the skin—they can often reflect broader cardiovascular risks. Given the overlap between dermatology and cardiology, knowing how to spot warning signs early and what steps to take during routine visits is key to comprehensive care. Joining Dr. Mary Cheeley to discuss the connection between the skin and the heart are Drs. Joel Gelfand and Michael Garshick. Dr. Gelfand is a dermatologist at the University of Pennsylvania and the Director of the Psoriasis and Phototherapy Treatment Center and the Center for Clinical Sciences in Dermatology. Dr. Garshick is a cardiologist and the Director of the Cardio-Rheumatology Program at NYU Langone Health, as well as an Assistant Professor of Medicine and Dermatology at NYU Grossman School of Medicine.

Duration:00:11:59

Ask host to enable sharing for playback control

Beyond the Scale: How to Tackle Obesity’s Comorbidities

5/30/2025
This 5-part series redefines obesity as a chronic, biologically driven disease. It addresses the impact of stigma, the management of common comorbidities, and the full spectrum of treatment options—from lifestyle interventions to GLP-1 receptor agonists and bariatric surgery. Practical guidance, patient cases, and expert insights help primary care providers deliver respectful, effective, and sustainable obesity care.

Duration:00:04:34

Ask host to enable sharing for playback control

Treating Obesity: Lifelong Strategies from Lifestyle to Pharmacotherapy and Surgery Treating Obesity: Lifelong Strategies fFrom Lifestyle to Pharmacotherapy and Surgery

5/30/2025
This 5-part series redefines obesity as a chronic, biologically driven disease. It addresses the impact of stigma, the management of common comorbidities, and the full spectrum of treatment options—from lifestyle interventions to GLP-1 receptor agonists and bariatric surgery. Practical guidance, patient cases, and expert insights help primary care providers deliver respectful, effective, and sustainable obesity care.

Duration:00:05:15

Ask host to enable sharing for playback control

Practical Tips for GLP-1 RA Therapy Success

5/30/2025
This 5-part series redefines obesity as a chronic, biologically driven disease. It addresses the impact of stigma, the management of common comorbidities, and the full spectrum of treatment options—from lifestyle interventions to GLP-1 receptor agonists and bariatric surgery. Practical guidance, patient cases, and expert insights help primary care providers deliver respectful, effective, and sustainable obesity care.

Duration:00:05:15

Ask host to enable sharing for playback control

Obesity and Comorbidities: Strategies for Effective Patient Management

5/30/2025
This 5-part series redefines obesity as a chronic, biologically driven disease. It addresses the impact of stigma, the management of common comorbidities, and the full spectrum of treatment options—from lifestyle interventions to GLP-1 receptor agonists and bariatric surgery. Practical guidance, patient cases, and expert insights help primary care providers deliver respectful, effective, and sustainable obesity care.

Duration:00:05:00

Ask host to enable sharing for playback control

Obesity: Unmasking the Chronic Disease Beneath the Weight

5/30/2025
This 5-part series redefines obesity as a chronic, biologically driven disease. It addresses the impact of stigma, the management of common comorbidities, and the full spectrum of treatment options—from lifestyle interventions to GLP-1 receptor agonists and bariatric surgery. Practical guidance, patient cases, and expert insights help primary care providers deliver respectful, effective, and sustainable obesity care.

Duration:00:07:43

Ask host to enable sharing for playback control

Establishing Best Practices for Collaborative Care for Patients with ASCVD Between Academic and Rural Providers

4/3/2025
Host: Ty J. Gluckman, MD, MHA, FACC, FAHA, FASPC Host: Rishi Wadhera, MD, MPP, Mphil This on-demand knowledge primer explores key challenges and evidence-based strategies for improving atherosclerotic cardiovascular disease (ASCVD) management in rural populations. Led by two expert faculty members, the program provides a comprehensive overview of disparities in ASCVD care, guideline-directed therapies, and practical approaches to overcoming barriers in rural settings. Participants will gain essential knowledge to enhance patient outcomes and optimize cardiovascular care in underserved communities.
Ask host to enable sharing for playback control

Mode of Death in Patients With HFmrEF/HFpEF: The FINEARTS-HF Trial

4/1/2025
Guest: Akshay S. Desai, MD These video briefs feature expert insights on the latest clinical data presented at ACC 2025. Leading cardiologists discuss emerging nonsteroidal mineralocorticoid receptor antagonists (MRAs), their efficacy in heart failure management, and their potential advantages over traditional steroidal MRAs. The series explores key trial findings, safety considerations, and clinical implications for optimizing patient care. Viewers will gain practical knowledge on integrating these novel therapies into clinical practice to improve patient outcomes.
Ask host to enable sharing for playback control

Tailoring First-Line Regimens: Patient-Centric Selection in Metastatic ESCC

3/31/2025
Host: Harry Yoon, MD Host: Jaffer Ajani, MD This online CME activity focuses on the first-line treatment of advanced or metastatic esophageal squamous cell carcinoma (ESCC) with the addition of an immune checkpoint inhibitor (ICI) to chemotherapy. Participants will learn about anti-PD-1 agents for ESCC that are either approved or are actively being investigated, along with their differentiating features; practice-changing data; and current guideline recommendations to inform first-line treatment selection decisions for patients with metastatic ESCC. Strategies to monitor and mitigate adverse effects associated with the use of combination ICI and chemotherapy regimens to optimize treatment adherence and patient outcomes will also be explored. Please stay tuned for additional content to this program available for credit. The maximum amount of credit available for the entire activity 0.75.
Ask host to enable sharing for playback control

ICI Combination Regimens for First-Line Treatment of Metastatic ESCC

3/31/2025
Host: Harry Yoon, MD Host: Jaffer Ajani, MD This online CME activity focuses on the first-line treatment of advanced or metastatic esophageal squamous cell carcinoma (ESCC) with the addition of an immune checkpoint inhibitor (ICI) to chemotherapy. Participants will learn about anti-PD-1 agents for ESCC that are either approved or are actively being investigated, along with their differentiating features; practice-changing data; and current guideline recommendations to inform first-line treatment selection decisions for patients with metastatic ESCC. Strategies to monitor and mitigate adverse effects associated with the use of combination ICI and chemotherapy regimens to optimize treatment adherence and patient outcomes will also be explored. Please stay tuned for additional content to this program available for credit. The maximum amount of credit available for the entire activity 0.75.
Ask host to enable sharing for playback control

The Impact of First-Line Treatment on Subsequent Treatment Options for Metastatic ESCC

3/31/2025
Host: Harry Yoon, MD Host: Jaffer Ajani, MD This online CME activity focuses on the first-line treatment of advanced or metastatic esophageal squamous cell carcinoma (ESCC) with the addition of an immune checkpoint inhibitor (ICI) to chemotherapy. Participants will learn about anti-PD-1 agents for ESCC that are either approved or are actively being investigated, along with their differentiating features; practice-changing data; and current guideline recommendations to inform first-line treatment selection decisions for patients with metastatic ESCC. Strategies to monitor and mitigate adverse effects associated with the use of combination ICI and chemotherapy regimens to optimize treatment adherence and patient outcomes will also be explored. Please stay tuned for additional content to this program available for credit. The maximum amount of credit available for the entire activity 0.75.
Ask host to enable sharing for playback control

Strategies for Navigating First-Line Treatment Selection in Metastatic ESCC

3/31/2025
Host: Harry Yoon, MD Host: Jaffer Ajani, MD This online CME activity focuses on the first-line treatment of advanced or metastatic esophageal squamous cell carcinoma (ESCC) with the addition of an immune checkpoint inhibitor (ICI) to chemotherapy. Participants will learn about anti-PD-1 agents for ESCC that are either approved or are actively being investigated, along with their differentiating features; practice-changing data; and current guideline recommendations to inform first-line treatment selection decisions for patients with metastatic ESCC. Strategies to monitor and mitigate adverse effects associated with the use of combination ICI and chemotherapy regimens to optimize treatment adherence and patient outcomes will also be explored. Please stay tuned for additional content to this program available for credit. The maximum amount of credit available for the entire activity 0.75.
Ask host to enable sharing for playback control

Advancing Cardiology and Heart Surgery Through a History of Collaboration

3/14/2025
Guest: Craig Smith, MD On this episode of Advances in Care, host Erin Welsh and Dr. Craig Smith, Chair of the Department of Surgery and Surgeon-in-Chief at NewYork-Presbyterian and Columbia discuss the highlights of Dr. Smith’s 40+ year career as a cardiac surgeon and how the culture of Columbia has been a catalyst for innovation in cardiac care. Dr. Smith describes the excitement of helping to pioneer the institution’s heart transplant program in the 1980s, when it was just one of only three hospitals in the country practicing heart transplantation. Dr. Smith also explains how a unique collaboration with Columbia’s cardiology team led to the first of several groundbreaking trials, called PARTNER (Placement of AoRTic TraNscatheteR Valve), which paved the way for a monumental treatment for aortic stenosis — the most common heart valve disease that is lethal if left untreated. During the trial, Dr. Smith worked closely with Dr. Martin B. Leon, Professor of Medicine at Columbia University Irving Medical Center and Chief Innovation Officer and the Director of the Cardiovascular Data Science Center for the Division of Cardiology. Their findings elevated TAVR, or transcatheter aortic valve replacement, to eventually become the gold-standard for aortic stenosis patients at all levels of illness severity …
Ask host to enable sharing for playback control

Novel Transcatheter Solution Approved for Tricuspid Regurgitation

3/14/2025
Guest: Susheel Kodali, MD Susheel Kodali, MD, director of the Structural Heart and Valve Center at NewYork-Presbyterian and Columbia, shares more about an innovative transcatheter therapy for tricuspid regurgitation (TR), which is providing a new treatment option that vastly improves quality of life. Results from the TRISCEND II trial demonstrated the safety and efficacy of a tricuspid valve replacement system, which was fast-tracked for FDA approval due to its clear benefit for the vulnerable TR patient population. © 2025 NewYork-Presbyterian
Ask host to enable sharing for playback control

Elevating Care for Patients With Severe Renal Disease in AAV

2/14/2025
Host: Silke R. Brix, MD, MRCP, SCPR Guest: Andreas Kronbichler, MD Blood vessel inflammation that occurs with anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis – or AAV – often results in damage that can lead to multi-organ involvement. This makes early diagnosis of this rare, autoimmune disease important for developing an effective treatment plan and personalized treatment selection a key success factor in the optimization of patient care.
Ask host to enable sharing for playback control

Optimizing AAV Outcomes: Maintenance Therapies

2/14/2025
Host: Bernhard Hellmich, MD Guest: Silke R. Brix, MD, MRCP, SCPR Blood vessel inflammation that occurs with anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis – or AAV – often results in damage that can lead to multi-organ involvement. This makes early diagnosis of this rare, autoimmune disease important for developing an effective treatment plan and personalized treatment selection a key success factor in the optimization of patient care.
Ask host to enable sharing for playback control

Patient Case Study: Obesity and VTE

2/14/2025
Host: Renato D. Lopes, MD, MHS, PhD Guest: Alexander T. Cohen, MD, MBBS The effective management of atrial fibrillation (AF) remains a high priority for many clinicians worldwide because a significant number of people globally who are living with AF are at risk of developing venous thromboembolism (VTE). This makes our understanding and implementation of new findings and clinical trial outcomes that much more important as we develop effective, personalized treatment plans for our patients. Tune in to our micro learning course to make sure you’re up to date and providing the care your patients deserve.
Ask host to enable sharing for playback control

Patient Case Study: Elderly

2/14/2025
Host: Renato D. Lopes, MD, MHS, PhD Guest: Valeria Caso, MD, PhD The effective management of atrial fibrillation (AF) remains a high priority for many clinicians worldwide because a significant number of people globally who are living with AF are at risk of developing venous thromboembolism (VTE). This makes our understanding and implementation of new findings and clinical trial outcomes that much more important as we develop effective, personalized treatment plans for our patients. Tune in to our micro learning course to make sure you’re up to date and providing the care your patients deserve.
Ask host to enable sharing for playback control

Implications Associated With Integrating Both Real-World Data and Clinical Trial Data Into Clinical Practice: AF Considerations

2/14/2025
Guest: Valeria Caso, MD, PhD The effective management of atrial fibrillation (AF) remains a high priority for many clinicians worldwide because a significant number of people globally who are living with AF are at risk of developing venous thromboembolism (VTE). This makes our understanding and implementation of new findings and clinical trial outcomes that much more important as we develop effective, personalized treatment plans for our patients. Tune in to our micro learning course to make sure you’re up to date and providing the care your patients deserve.